Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

ABSTRACT: The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2319845 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR